2002 news stories
New treatment approved for psoriatic arthritis Jan. 16, 2002
News briefs from American Academy of Dermatology annual meeting Feb. 23, 2002
World's leading psoriasis researchers gather in France April 25, 2002
Researchers agree to pursue HLA-cw6 gene May 2002
National Psoriasis Foundation to testify before FDA panel reviewing new psoriasis drug May 6, 2002
Delays for Enbrel continue May 24, 2002
FDA panel recommends approval of new psoriasis drug May 24, 2002
Social miscues: Understanding stigmas July 26, 2002
The research pipeline for psoriasis Sept. , 2002
2002 National Conference overview Sept. 13, 2002
2002 National Conference summary: Friday Sept. 13, 2002
2002 National Conference summary: Saturday morning Sept. 13, 2002
2002 National Conference summary: Saturday afternoon Sept. 13, 2002
2002 National Conference summary: Saturday evening Sept. 13, 2002
2002 National Conference summary: Sunday Sept. 13, 2002
2002 National Conference: On the scene Sept. 13, 2002
2002 National Conference: Workshop speakers Sept. 13, 2002
2002 National Conference: Youth track Sept. 13, 2002
FDA to complete Amevive review within 6 months Sept. 13, 2002
Study consistent with previous Raptiva findings Sept. 19, 2002
How much does skin disease cost? Sept. 19, 2002
National Psoriasis Foundation lobbies for more research funding Sept. 19, 2002
Gene update: Discovery of potential psoriasis gene in Sweden Oct. 18, 2002
Rheumatology researchers find hope in Remicade Nov. 11, 2002
FDA approves Olux for the body Dec. 3, 2002
Amgen resolves Enbrel supply issue Dec. 19, 2002
Smallpox and psoriasis Dec. 19, 2002
Raptiva filed for FDA approval Dec. 23, 2002
FDA approves Enbrel plant in Rhode Island Dec. 23, 2002
| 
